|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2004-9-16
|
|
pubmed:abstractText |
Ataxia is caused by a variety of conditions leading to imbalance, incoordination and other disabilities. Current treatment is largely symptomatic. Ondansetron (a 5-HT3 antagonist) has been established as an anti-emetic in cancer patients, but has recently been shown to improve vertigo and cerebellar tremor in some patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0269-9052
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1025-39
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:15370901-Adult,
pubmed-meshheading:15370901-Brain Injury, Chronic,
pubmed-meshheading:15370901-Cerebellar Ataxia,
pubmed-meshheading:15370901-Female,
pubmed-meshheading:15370901-Humans,
pubmed-meshheading:15370901-Male,
pubmed-meshheading:15370901-Middle Aged,
pubmed-meshheading:15370901-Neuropsychological Tests,
pubmed-meshheading:15370901-Ondansetron,
pubmed-meshheading:15370901-Postural Balance,
pubmed-meshheading:15370901-Sensation Disorders,
pubmed-meshheading:15370901-Serotonin Antagonists,
pubmed-meshheading:15370901-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
A preliminary study of the efficacy of ondansetron in the treatment of ataxia, poor balance and incoordination from brain injury.
|
|
pubmed:affiliation |
University of Toronto, Toronto, Ontario, Canada.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
